Immutep IMMP
NASDAQ IMMP
$3.32 +0.09 (+2.89%)
As of: Oct 21, 2026 · 1:16 PM EDT

Immutep (IMMP) Receivables - Other (2021)

Updated

Immutep (IMMP) reported Receivables - Other of $1.36 million for the quarter ended Dec 31, 2021.

Analysis

Immutep (IMMP) Receivables - Other (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.17 Bn 1,102.76 Bn 19.71 Bn
2 Johnson & Johnson 615.84 Bn 534.36 Bn 17.26 Bn
3 AbbVie 500.69 Bn 473.80 Bn 12.70 Bn
4 Merck 367.34 Bn 321.72 Bn 12.21 Bn
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.75 Bn 12.86 Bn
7 Amgen 235.51 Bn 190.91 Bn 7.24 Bn
8 Gilead Sciences 190.60 Bn 164.80 Bn 6.22 Bn
9 Pfizer 169.37 Bn 116.02 Bn 10.94 Bn
10 Immutep 24.19 Mn -186.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 1.36 Mn
API Access

Immutep Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=IMMP&period=max&api_key=YOUR_API_KEY